摘要
With the rapid increase of quality submission of manuscripts and published articles, Chinese Herbal Medicines （CHM） has been quickly developing into an enlightening journal for the readers and researchers in the field of traditional Chinese medicine （TCM） in recent years. In particular, some of the extraordinary important areas and topics dealing with the methodologies and criteria for quality, safety, and efficacy assessment of CHMs and their pharmaceutical preparations have been intensively addressed. For this issue, I am grateful and thankful to the Editorial Committee of CHM for inviting me to write an editorial on the topic of integrated network research of TCM. Also, I am delighted to read three review articles regarding the advancement of network research in CHMs. In fact, CHMs are characterized by ＂three multi-＇s＂ advantageous nature, i.e. the ＂multi-chemical components＂, ＂multi-pharmacological effects,＂ and ＂multi-action targets and pathways＂, that are intended to holistically and optimally modulate a person＇s physiological/pathological networks, especially in a circumstance of systematic disease or complicated pathological condition.
With the rapid increase of quality submission of manuscripts and published articles, Chinese Herbal Medicines （CHM） has been quickly developing into an enlightening journal for the readers and researchers in the field of traditional Chinese medicine （TCM） in recent years. In particular, some of the extraordinary important areas and topics dealing with the methodologies and criteria for quality, safety, and efficacy assessment of CHMs and their pharmaceutical preparations have been intensively addressed. For this issue, I am grateful and thankful to the Editorial Committee of CHM for inviting me to write an editorial on the topic of integrated network research of TCM. Also, I am delighted to read three review articles regarding the advancement of network research in CHMs. In fact, CHMs are characterized by ＂three multi-＇s＂ advantageous nature, i.e. the ＂multi-chemical components＂, ＂multi-pharmacological effects,＂ and ＂multi-action targets and pathways＂, that are intended to holistically and optimally modulate a person＇s physiological/pathological networks, especially in a circumstance of systematic disease or complicated pathological condition.
